Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.71 USD | +1.97% | -3.74% | -22.19% |
Mar. 13 | Transcript : Gossamer Bio, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 07:30 AM | |
Mar. 12 | Gossamer Bio Announces Board of Directors Appointments | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 161M |
---|---|---|---|---|---|
Net income 2024 * | -180M | Net income 2025 * | -196M | EV / Sales 2024 * | - |
Net cash position 2024 * | 13.32M | Net cash position 2025 * | 23.83M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.96
x | P/E ratio 2025 * |
-1.01
x | Employees | 135 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.76% |
Latest transcript on Gossamer Bio, Inc.
1 day | +1.97% | ||
1 week | -3.74% | ||
1 month | -39.83% | ||
3 months | -15.48% | ||
6 months | +42.00% | ||
Current year | -22.19% |
Managers | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Bryan Giraudo
DFI | Director of Finance/CFO | 48 | 18-05-06 |
Chief Tech/Sci/R&D Officer | - | 23-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Thomas Daniel
BRD | Director/Board Member | 69 | 17-12-31 |
Skye Drynan
BRD | Director/Board Member | - | Mar. 10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.71 | +1.97% | 1,114,955 |
24-04-29 | 0.6963 | +4.24% | 1,252,793 |
24-04-26 | 0.668 | -0.30% | 2,084,401 |
24-04-25 | 0.67 | -5.41% | 2,484,614 |
24-04-24 | 0.7083 | -3.97% | 798,638 |
Delayed Quote Nasdaq, April 30, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.19% | 161M | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- GOSS Stock